Literature DB >> 3517056

Immunoblot analysis of the serological response in invasive Trichosporon beigelii and Blastoschizomyces capitatus infections.

R C Matthews, J P Burnie, A Fox, M Woods, S Tabaqchali.   

Abstract

The serological response to Trichosporon sp. was examined by the immunoblot technique. Antibodies to a range of antigens (200 to 16 kilodaltons) were detectable in three patients with invasive Trichosporon beigelii or Blastoschizomyces capitatus infections and 10 uninfected controls. High levels of preexisting antibodies may contribute to the rarity of systemic infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3517056      PMCID: PMC268655          DOI: 10.1128/jcm.23.2.395-397.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  [Recent causal organisms of bacteremia and a case of septicemia caused by Trichosporon cutaneum (author's transl)].

Authors:  E Terashima; T Tsuchiya; K Okuyama
Journal:  Kansenshogaku Zasshi       Date:  1978-04

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Postoperative endophthalmitis due to Trichosporon cutaneum.

Authors:  H A Sheikh; S Mahgoub; K Badi
Journal:  Br J Ophthalmol       Date:  1974-06       Impact factor: 4.638

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Trichosporon sepsis and leukemia.

Authors:  R Rivera; A Cangir
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

7.  Systemic mycosis due to Trichosporon cutaneum: a report of two additional cases.

Authors:  H L Evans; M Kletzel; R D Lawson; L S Frankel; R L Hopfer
Journal:  Cancer       Date:  1980-01-15       Impact factor: 6.860

8.  The prevalence of yeasts in clinical specimens from cancer patients.

Authors:  T E Kiehn; F F Edwards; D Armstrong
Journal:  Am J Clin Pathol       Date:  1980-04       Impact factor: 2.493

9.  Disseminated Trichosporon capitatum infection in an immunosuppressed host.

Authors:  D J Winston; G E Balsley; J Rhodes; S R Linné
Journal:  Arch Intern Med       Date:  1977-09

10.  Disseminated Trichosporon infection. Occurrence in an immunosuppressed patient with chronic active hepatitis.

Authors:  N Kirmani; C U Tuazon; G W Geelhoed
Journal:  Arch Intern Med       Date:  1980-02
View more
  6 in total

1.  Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients.

Authors:  D D'Antonio; A Mazzoni; A Iacone; B Violante; M A Capuani; F Schioppa; F Romano
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

2.  First report of chronic meningitis caused by Trichosporon beigelii.

Authors:  I Surmont; B Vergauwen; L Marcelis; L Verbist; G Verhoef; M Boogaerts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

3.  Immunoblot analysis of antibody responses to Sporothrix schenckii.

Authors:  E N Scott; H G Muchmore
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

4.  DNA relatedness, taxonomy, and medical significance of Geotrichum capitatum.

Authors:  E Guého; G S de Hoog; M T Smith; S A Meyer
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

Review 5.  Cutaneous defenses against dermatophytes and yeasts.

Authors:  D K Wagner; P G Sohnle
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

Review 6.  Uncommon yeastlike zoopathogens and commercial systems for their identification.

Authors:  G A Land; I F Salkin
Journal:  Mycopathologia       Date:  1987-09       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.